FGF21 is associated with metabolic conditions such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD), where its levels are paradoxically elevated, possibly as a compensatory mechanism or due to resistance [104,105]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.